These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 19344978)

  • 41. Factors associated with recurrence of venous leg ulcers: a survey and retrospective chart review.
    Finlayson K; Edwards H; Courtney M
    Int J Nurs Stud; 2009 Aug; 46(8):1071-8. PubMed ID: 19185862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Local therapy and treatment costs of chronic, venous leg ulcers with electrical stimulation (Dermapulse): a prospective, placebo controlled, double blind trial.
    Jünger M; Arnold A; Zuder D; Stahl HW; Heising S
    Wound Repair Regen; 2008; 16(4):480-7. PubMed ID: 18638265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spatial distribution of mast cells in chronic venous leg ulcers.
    Abd-El-Aleem SA; Morgan C; Ferguson MW; McCollum CN; Ireland GW
    Eur J Histochem; 2005; 49(3):265-72. PubMed ID: 16216812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sedentary patients with venous or mixed leg ulcers: determinants of physical activity.
    Heinen MM; Evers AW; Van Uden CJ; Van der Vleuten CJ; van de Kerkhof PC; Van Achterberg T
    J Adv Nurs; 2007 Oct; 60(1):50-7. PubMed ID: 17824939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early healing rates and wound area measurements are reliable predictors of later complete wound closure.
    Cardinal M; Eisenbud DE; Phillips T; Harding K
    Wound Repair Regen; 2008; 16(1):19-22. PubMed ID: 18211575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human beta-defensin-2 expression is increased in chronic wounds.
    Butmarc J; Yufit T; Carson P; Falanga V
    Wound Repair Regen; 2004; 12(4):439-43. PubMed ID: 15260809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease.
    Ackerman Z; Seidenbaum M; Loewenthal E; Rubinow A
    Arch Dermatol; 1988 Sep; 124(9):1376-8. PubMed ID: 3415280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of matrix metalloproteinases in venous leg ulcers development].
    Bogaczewicz J; Dudek W; Wroński J; Chodorowska G; Przywara S; Krasowska D; Zubilewicz T
    Pol Merkur Lekarski; 2005 Nov; 19(113):686-92. PubMed ID: 16498813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions.
    Simka M; Rybak Z
    Med Hypotheses; 2008 Aug; 71(2):293-7. PubMed ID: 18400414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers.
    Trengove NJ; Bielefeldt-Ohmann H; Stacey MC
    Wound Repair Regen; 2000; 8(1):13-25. PubMed ID: 10760211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased levels of human neutrophil alpha-defensins in chronic venous leg ulcers.
    Lundqvist K; Sørensen OE; Schmidtchen A
    J Dermatol Sci; 2008 Aug; 51(2):131-4. PubMed ID: 18472248
    [No Abstract]   [Full Text] [Related]  

  • 52. Causes and effects of the chronic inflammation in venous leg ulcers.
    Agren MS; Eaglstein WH; Ferguson MW; Harding KG; Moore K; Saarialho-Kere UK; Schultz GS
    Acta Derm Venereol Suppl (Stockh); 2000; 210():3-17. PubMed ID: 10884942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical treatment of chronic venous ulcers with sucralfate: a placebo controlled randomized study.
    Tumino G; Masuelli L; Bei R; Simonelli L; Santoro A; Francipane S
    Int J Mol Med; 2008 Jul; 22(1):17-23. PubMed ID: 18575771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leg ulcers: uncommon presentations.
    Gottrup F; Karlsmark T
    Clin Dermatol; 2005; 23(6):601-11. PubMed ID: 16325069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isosorbide dinitrate spray as therapeutic strategy for treatment of chronic venous ulcers.
    Sánchez-Vázquez R; Briseño-Rodríguez G; Cardona-Muñoz EG; Gálvez-Gastélum FJ; Totsuka-Sutto SE; Garcia-Benavides L
    Angiology; 2008; 59(1):64-71. PubMed ID: 18319224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of symptom clusters in patients with chronic venous leg ulcers.
    Edwards H; Finlayson K; Skerman H; Alexander K; Miaskowski C; Aouizerat B; Gibb M
    J Pain Symptom Manage; 2014 May; 47(5):867-75. PubMed ID: 23998779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A histopathologic basis for surgical debridement to promote healing of venous ulcers.
    Blumberg SN; Maggi J; Melamed J; Golinko M; Ross F; Chen W
    J Am Coll Surg; 2012 Dec; 215(6):751-7. PubMed ID: 22981433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs.
    Sedov VM; Andreev DY; Smirnova TD; Paramonov BA; Enkina TN; Sominina AA; Kiselev OI; Suissi YY; Lebedev LV
    Angiol Sosud Khir; 2007; 13(1):65-75. PubMed ID: 17679976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The altered expression of syndecan 4 in the uninvolved skin of venous leg ulcer patients may predispose to venous leg ulcer.
    Nagy N; Németh IB; Szabad G; Szolnoky G; Belsõ N; Bata-Csörgõ Z; Dobozy A; Kemény L; Széll M
    Wound Repair Regen; 2008; 16(4):495-502. PubMed ID: 18638267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postural vasoregulation and mediators of reperfusion injury in venous ulceration.
    He CF; Cherry GW; Arnold F
    J Vasc Surg; 1997 Apr; 25(4):647-53. PubMed ID: 9129619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.